Comparing Clearances of Polymethylmethacrylate and Polysulfone Dialyzer Membranes for Postdilution Hemodiafiltration in Patients With Kidney Failure: Protocol for a Systematic Review and Meta-Analysis
- PMID: 40570345
- PMCID: PMC12246762
- DOI: 10.2196/71943
Comparing Clearances of Polymethylmethacrylate and Polysulfone Dialyzer Membranes for Postdilution Hemodiafiltration in Patients With Kidney Failure: Protocol for a Systematic Review and Meta-Analysis
Abstract
Background: Kidney replacement therapy (KRT) is needed by patients with kidney failure to eliminate metabolic waste. When kidney transplantation is not feasible, hemodialysis (HD) is performed. Hemodiafiltration (HDF) provides a better solute clearance than conventional HD due to its higher convective dose. The clearance performances of HDF also depend on the type of dialysis membrane used. Polysulfone (PS) membranes have been used since 1965 due to their excellent resistance and biocompatibility. However, the newer generation of polymethylmethacrylate (PMMA) membranes offers comparable convective capacity with reduced albumin loss.
Objective: The forthcoming study aims to compare the solute clearance of postdilution HDF using PMMA versus PS dialyzer membranes in patients with kidney failure requiring long-term HD.
Methods: The literature search will use databases including PubMed, Scopus, Web of Science, Embase, and Cochrane. Two independent reviewers will select studies and assess their quality. Pooled estimates of relevant factors will be computed via a random-effects model using Stata/BE 18 (StataCorp) software. The reporting of findings will adhere to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines.
Results: The search and screening for the systematic literature review are expected to be completed in May 2026. Data extraction, quality appraisal, and subsequent data synthesis will begin in June 2026. The review should be completed by October 2026, and the study results will be published in 2027.
Conclusions: Dialyzer membrane clearance determines HD quality. Nevertheless, many middle uremic molecules are poorly cleared with conventional HD. Consequently, HDF was invented to improve their clearance. Among the most widely used dialyzer membranes, PS and PMMA are used in the newer generation of HDF. Nevertheless, no available systematic reviews have compared the efficacy of the 2 dialyzer membrane materials. Although no ideal dialyzer can efficiently remove all types of uremic toxins while retaining essential elements, improving solute clearance should benefit patients. This information could help clinicians determine which membrane to use in HDF.
Trial registration: PROSPERO CRD42024603277; https://www.crd.york.ac.uk/PROSPERO/view/CRD42024603277.
International registered report identifier (irrid): PRR1-10.2196/71943.
Keywords: albumin; beta 2-microglobulin; creatinine; dialysis; end stage kidney disease; polymethyl methacrylate; polysulfone.
©Cahyani Gita Ambarsari, Astrid Kristina Kardani, Agustina Wulandari, Nadhifah Nadhifah. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 26.06.2025.
Conflict of interest statement
Conflicts of Interest: None declared.
Similar articles
-
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.Cochrane Database Syst Rev. 2001;(3):CD003234. doi: 10.1002/14651858.CD003234. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003234. doi: 10.1002/14651858.CD003234.pub2. PMID: 11687058 Updated.
-
Removal of α1-Microglobulin Using Post-Dilution Online Hemodiafiltration with Polymethylmethacrylate Membrane: An Open-Label, Single-Arm Study.Blood Purif. 2024;53(2):123-129. doi: 10.1159/000534459. Epub 2023 Nov 8. Blood Purif. 2024. PMID: 37939684
-
Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.Cochrane Database Syst Rev. 2015 May 20;2015(5):CD006258. doi: 10.1002/14651858.CD006258.pub2. Cochrane Database Syst Rev. 2015. PMID: 25993563 Free PMC article.
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
-
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100. Epidemiol Prev. 2013. PMID: 23851286 Italian.
References
-
- Santoso DN, Sinuraya FAG, Ambarsari CG. Distal renal tubular acidosis presenting with an acute hypokalemic paralysis in an older child with severe vesicoureteral reflux and syringomyelia: a case report. BMC Nephrol. 2022 Jul 14;23(1):248. doi: 10.1186/s12882-022-02874-9. https://www.biomedcentral.com/1471-2369/23/248 10.1186/s12882-022-02874-9 - DOI - PMC - PubMed
-
- Ambarsari CG, Agianda HAP, Saraswati M, Kim JJ. Dent disease 1 presented early with Bartter-Like cyndrome features and rickets: A case report. Case Rep Nephrol Dial. 2025 Jan 21;15(1):15–25. doi: 10.1159/000543719. - DOI
-
- Ambarsari CG, Tambunan T, Pardede SO, Fazlur Rahman FH, Kadaristiana A. Role of dipstick albuminuria in progression of paediatric chronic kidney disease. J Pak Med Assoc. 2021 Feb;71(Suppl 2)(2):S103–S106. - PubMed
-
- Zhang L, Guo Y, Ming H. Effects of hemodialysis, peritoneal dialysis, and renal transplantation on the quality of life of patients with end-stage renal disease. Rev Assoc Med Bras (1992) 2020 Sep;66(9):1229–1234. doi: 10.1590/1806-9282.66.9.1229. https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-4230202000... S0104-42302020000901229 - DOI - PubMed
-
- Ambarsari CG, Cho Y, Milanzi E, Francis A, Koh LJ, Lalji R, Johnson DW. Epidemiology and outcomes of children with kidney failure receiving kidney replacement therapy in Australia and New Zealand. Kidney Int Rep. 2023 Oct;8(10):1951–1964. doi: 10.1016/j.ekir.2023.07.006. https://linkinghub.elsevier.com/retrieve/pii/S2468-0249(23)01384-0 S2468-0249(23)01384-0 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous